Ricci E, Giaccone M, Pecchio F, Lale-Murix E, De Simone M, Nano M
Istituto di Patologia Chirurgica, Università degli Studi di Torino.
Minerva Chir. 1991 May 31;46(10):507-10.
The paper reports a study which was carried out to assess immunological function by assaying IL2 in cancer-operated patients treated with thymostimulin. The results of the study show that, used in normally fed, immunodepressed patients, this immunomodulator is able to normalise levels of lymphocyte subpopulations and to bring serum concentrations of IL2-RS to the levels of normoergic patients.
该论文报道了一项旨在通过检测接受胸腺刺激素治疗的癌症手术患者的白细胞介素-2（IL2）来评估免疫功能的研究。研究结果表明，对于正常进食的免疫抑制患者，这种免疫调节剂能够使淋巴细胞亚群水平恢复正常，并使白细胞介素-2受体（IL2-RS）的血清浓度达到正常能量水平患者的水平。
